Titre : Hyperthyroïdie

Hyperthyroïdie : Questions médicales fréquentes

Termes MeSH sélectionnés :

Guidelines as Topic
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Hyperthyroïdie : Questions médicales les plus fréquentes", "headline": "Hyperthyroïdie : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Hyperthyroïdie : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-07", "dateModified": "2025-05-02", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Hyperthyroïdie" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Maladies de la thyroïde", "url": "https://questionsmedicales.fr/mesh/D013959", "about": { "@type": "MedicalCondition", "name": "Maladies de la thyroïde", "code": { "@type": "MedicalCode", "code": "D013959", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C19.874" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Thyréotoxicose", "alternateName": "Thyrotoxicosis", "url": "https://questionsmedicales.fr/mesh/D013971", "about": { "@type": "MedicalCondition", "name": "Thyréotoxicose", "code": { "@type": "MedicalCode", "code": "D013971", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C19.874.397.685" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Crise thyréotoxique", "alternateName": "Thyroid Crisis", "url": "https://questionsmedicales.fr/mesh/D013958", "about": { "@type": "MedicalCondition", "name": "Crise thyréotoxique", "code": { "@type": "MedicalCode", "code": "D013958", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C19.874.397.685.905" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Hyperthyroïdie", "alternateName": "Hyperthyroidism", "code": { "@type": "MedicalCode", "code": "D006980", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "M Trebillod", "url": "https://questionsmedicales.fr/author/M%20Trebillod", "affiliation": { "@type": "Organization", "name": "Service d'Endocrinologie, CHU Liège, Belgique." } }, { "@type": "Person", "name": "P Pétrossians", "url": "https://questionsmedicales.fr/author/P%20P%C3%A9trossians", "affiliation": { "@type": "Organization", "name": "Service d'Endocrinologie, CHU Liège, Belgique." } }, { "@type": "Person", "name": "Priya Vaidyanathan", "url": "https://questionsmedicales.fr/author/Priya%20Vaidyanathan", "affiliation": { "@type": "Organization", "name": "Department of Pediatric Endocrinology, Children's National Hospital, Washington, DC 20010, USA. Electronic address: pvaidyan@childrensnational.org." } }, { "@type": "Person", "name": "David L Panciera", "url": "https://questionsmedicales.fr/author/David%20L%20Panciera", "affiliation": { "@type": "Organization", "name": "Department of Small Animal Clinical Sciences, Virginia-Maryland College of Veterinary Medicine, Blacksburg, Virginia, USA." } }, { "@type": "Person", "name": "Katie M Boes", "url": "https://questionsmedicales.fr/author/Katie%20M%20Boes", "affiliation": { "@type": "Organization", "name": "Department of Biomedical Sciences & Pathobiology, Virginia-Maryland College of Veterinary Medicine, Blacksburg, Virginia, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "The Clinical Utility of Post-Transplant Monitoring of Donor-Specific Antibodies in Stable Renal Transplant Recipients: A Consensus Report With Guideline Statements for Clinical Practice.", "datePublished": "2023-07-25", "url": "https://questionsmedicales.fr/article/37560072", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/ti.2023.11321" } }, { "@type": "ScholarlyArticle", "name": "Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines for Occipital Nerve Stimulation for the Treatment of Patients With Medically Refractory Occipital Neuralgia: Update.", "datePublished": "2023-07-17", "url": "https://questionsmedicales.fr/article/37458729", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1227/neu.0000000000002578" } }, { "@type": "ScholarlyArticle", "name": "Retrospective analysis of serum free light chain reference intervals and risk for monoclonal gammopathy suggests different limits than those in international guidelines.", "datePublished": "2023-06-30", "url": "https://questionsmedicales.fr/article/37394225", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.clinbiochem.2023.110604" } }, { "@type": "ScholarlyArticle", "name": "Combination of expert guidelines-based and machine learning-based approaches leads to superior accuracy of automated prediction of clinical effect of copy number variations.", "datePublished": "2023-06-29", "url": "https://questionsmedicales.fr/article/37386017", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-023-37352-1" } }, { "@type": "ScholarlyArticle", "name": "Eligibility for vericiguat in a real-world heart failure population according to trial, guideline and label criteria: Data from the Swedish Heart Failure Registry.", "datePublished": "2023-06-29", "url": "https://questionsmedicales.fr/article/37323078", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/ejhf.2939" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies endocriniennes", "item": "https://questionsmedicales.fr/mesh/D004700" }, { "@type": "ListItem", "position": 3, "name": "Maladies de la thyroïde", "item": "https://questionsmedicales.fr/mesh/D013959" }, { "@type": "ListItem", "position": 4, "name": "Hyperthyroïdie", "item": "https://questionsmedicales.fr/mesh/D006980" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Hyperthyroïdie - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Hyperthyroïdie", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-13", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Hyperthyroïdie", "description": "Comment diagnostiquer l'hyperthyroïdie ?\nQuels examens sont utilisés pour confirmer l'hyperthyroïdie ?\nQuels symptômes indiquent une hyperthyroïdie ?\nQuel rôle joue la TSH dans le diagnostic ?\nPeut-on diagnostiquer l'hyperthyroïdie par des symptômes seuls ?", "url": "https://questionsmedicales.fr/mesh/D006980?mesh_terms=Guidelines+as+Topic&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Hyperthyroïdie", "description": "Quels sont les symptômes courants de l'hyperthyroïdie ?\nL'hyperthyroïdie cause-t-elle des problèmes de sommeil ?\nComment l'hyperthyroïdie affecte-t-elle le poids ?\nY a-t-il des symptômes oculaires associés ?\nL'hyperthyroïdie peut-elle causer des palpitations ?", "url": "https://questionsmedicales.fr/mesh/D006980?mesh_terms=Guidelines+as+Topic&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Hyperthyroïdie", "description": "Peut-on prévenir l'hyperthyroïdie ?\nLes antécédents familiaux influencent-ils le risque ?\nLe stress peut-il déclencher l'hyperthyroïdie ?\nUne alimentation équilibrée aide-t-elle ?\nLes carences en iode sont-elles un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D006980?mesh_terms=Guidelines+as+Topic&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Hyperthyroïdie", "description": "Quels traitements existent pour l'hyperthyroïdie ?\nComment fonctionnent les médicaments antithyroïdiens ?\nQuand est-ce que la chirurgie est nécessaire ?\nL'iode radioactif est-il un traitement efficace ?\nQuels effets secondaires peuvent avoir les traitements ?", "url": "https://questionsmedicales.fr/mesh/D006980?mesh_terms=Guidelines+as+Topic&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Hyperthyroïdie", "description": "Quelles sont les complications de l'hyperthyroïdie ?\nL'hyperthyroïdie peut-elle causer des problèmes cardiaques ?\nQu'est-ce qu'une crise thyroïdienne ?\nComment l'hyperthyroïdie affecte-t-elle les os ?\nY a-t-il des risques de complications psychologiques ?", "url": "https://questionsmedicales.fr/mesh/D006980?mesh_terms=Guidelines+as+Topic&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Hyperthyroïdie", "description": "Quels sont les principaux facteurs de risque ?\nLe sexe influence-t-il le risque d'hyperthyroïdie ?\nLes maladies auto-immunes sont-elles un facteur de risque ?\nL'âge joue-t-il un rôle dans le risque ?\nLes traitements antérieurs de la thyroïde augmentent-ils le risque ?", "url": "https://questionsmedicales.fr/mesh/D006980?mesh_terms=Guidelines+as+Topic&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer l'hyperthyroïdie ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic se fait par des tests sanguins mesurant les niveaux de TSH et T4 libre." } }, { "@type": "Question", "name": "Quels examens sont utilisés pour confirmer l'hyperthyroïdie ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des scintigraphies thyroïdiennes et des échographies peuvent être réalisées." } }, { "@type": "Question", "name": "Quels symptômes indiquent une hyperthyroïdie ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent perte de poids, nervosité, palpitations et insomnie." } }, { "@type": "Question", "name": "Quel rôle joue la TSH dans le diagnostic ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Une TSH basse indique souvent une hyperthyroïdie, car la thyroïde est hyperactive." } }, { "@type": "Question", "name": "Peut-on diagnostiquer l'hyperthyroïdie par des symptômes seuls ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Non, les symptômes doivent être confirmés par des tests sanguins." } }, { "@type": "Question", "name": "Quels sont les symptômes courants de l'hyperthyroïdie ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fatigue, irritabilité, tremblements et transpiration excessive." } }, { "@type": "Question", "name": "L'hyperthyroïdie cause-t-elle des problèmes de sommeil ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut entraîner des insomnies et des troubles du sommeil." } }, { "@type": "Question", "name": "Comment l'hyperthyroïdie affecte-t-elle le poids ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Elle provoque souvent une perte de poids malgré un appétit accru." } }, { "@type": "Question", "name": "Y a-t-il des symptômes oculaires associés ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des problèmes oculaires comme l'exophtalmie peuvent survenir." } }, { "@type": "Question", "name": "L'hyperthyroïdie peut-elle causer des palpitations ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les palpitations cardiaques sont un symptôme fréquent." } }, { "@type": "Question", "name": "Peut-on prévenir l'hyperthyroïdie ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de méthode de prévention spécifique, mais un suivi médical régulier aide." } }, { "@type": "Question", "name": "Les antécédents familiaux influencent-ils le risque ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un historique familial de maladies thyroïdiennes augmente le risque." } }, { "@type": "Question", "name": "Le stress peut-il déclencher l'hyperthyroïdie ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Le stress peut aggraver les symptômes, mais n'est pas une cause directe." } }, { "@type": "Question", "name": "Une alimentation équilibrée aide-t-elle ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée peut soutenir la santé thyroïdienne, mais ne prévient pas l'hyperthyroïdie." } }, { "@type": "Question", "name": "Les carences en iode sont-elles un facteur de risque ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Non, l'excès d'iode est plus souvent lié à l'hyperthyroïdie que la carence." } }, { "@type": "Question", "name": "Quels traitements existent pour l'hyperthyroïdie ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent les médicaments antithyroïdiens, l'iode radioactif et la chirurgie." } }, { "@type": "Question", "name": "Comment fonctionnent les médicaments antithyroïdiens ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Ils inhibent la production d'hormones thyroïdiennes par la glande thyroïde." } }, { "@type": "Question", "name": "Quand est-ce que la chirurgie est nécessaire ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La chirurgie est envisagée si les autres traitements échouent ou en cas de goitre volumineux." } }, { "@type": "Question", "name": "L'iode radioactif est-il un traitement efficace ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il est souvent utilisé pour détruire les cellules thyroïdiennes hyperactives." } }, { "@type": "Question", "name": "Quels effets secondaires peuvent avoir les traitements ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires incluent des éruptions cutanées, des douleurs articulaires et des troubles hépatiques." } }, { "@type": "Question", "name": "Quelles sont les complications de l'hyperthyroïdie ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des problèmes cardiaques, l'ostéoporose et la crise thyroïdienne." } }, { "@type": "Question", "name": "L'hyperthyroïdie peut-elle causer des problèmes cardiaques ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut entraîner des arythmies et une insuffisance cardiaque." } }, { "@type": "Question", "name": "Qu'est-ce qu'une crise thyroïdienne ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "C'est une urgence médicale avec une augmentation soudaine des hormones thyroïdiennes." } }, { "@type": "Question", "name": "Comment l'hyperthyroïdie affecte-t-elle les os ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut entraîner une diminution de la densité osseuse, augmentant le risque d'ostéoporose." } }, { "@type": "Question", "name": "Y a-t-il des risques de complications psychologiques ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'hyperthyroïdie peut provoquer anxiété et dépression chez certains patients." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'âge, le sexe féminin, et des antécédents familiaux de maladies thyroïdiennes." } }, { "@type": "Question", "name": "Le sexe influence-t-il le risque d'hyperthyroïdie ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les femmes sont plus susceptibles de développer une hyperthyroïdie que les hommes." } }, { "@type": "Question", "name": "Les maladies auto-immunes sont-elles un facteur de risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des maladies comme la maladie de Graves augmentent le risque d'hyperthyroïdie." } }, { "@type": "Question", "name": "L'âge joue-t-il un rôle dans le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque augmente avec l'âge, surtout chez les personnes de plus de 60 ans." } }, { "@type": "Question", "name": "Les traitements antérieurs de la thyroïde augmentent-ils le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des traitements comme la radiothérapie peuvent augmenter le risque d'hyperthyroïdie." } } ] } ] }

Sources (10000 au total)

The Clinical Utility of Post-Transplant Monitoring of Donor-Specific Antibodies in Stable Renal Transplant Recipients: A Consensus Report With Guideline Statements for Clinical Practice.

Solid phase immunoassays improved the detection and determination of the antigen-specificity of donor-specific antibodies (DSA) to human leukocyte antigens (HLA). The widespread use of SPI in kidney t...

Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines for Occipital Nerve Stimulation for the Treatment of Patients With Medically Refractory Occipital Neuralgia: Update.

The Guidelines Task Force conducted a systematic review of the relevant literature on occipital nerve stimulation (ONS) for occipital neuralgia (ON) to update the original 2015 guidelines to ensure ti... To conduct a systematic review of the literature and update the evidence-based guidelines on ONS for ON.... The Guidelines Task Force conducted another systematic review of the relevant literature, using the same search terms and strategies used to search PubMed and Embase for relevant literature. The updat... Nine studies were included in the original guideline, reporting the use of ONS as an effective treatment option for patients with medically refractory ON. An additional 6 studies were included in this... Based on the availability of new literature, the current article is a minor update only that does not result in modification of the prior recommendations: Clinicians may use ONS as a treatment option ...

Retrospective analysis of serum free light chain reference intervals and risk for monoclonal gammopathy suggests different limits than those in international guidelines.

Recent reference interval studies of the serum free light chain (FLC) test using contemporary instruments display divergence with the diagnostic range generally adopted as the international standard. ... Retrospective laboratory and clinical data for 8,986 patients were included in the study. Reference intervals were generated against a set of inclusion/exclusion criteria for two time periods represen... The 95% FLC ratio reference intervals were 0.76-2.38 for SPAPLUS®, and 0.68-1.82 for Optilite® instruments. These intervals varied considerably from the current diagnostic range of 0.26-1.65 and mappe... These findings corroborate recent reference interval studies and support recommendations for independent re-evaluation of intervals by institutions as well as an update of international guidelines....

Combination of expert guidelines-based and machine learning-based approaches leads to superior accuracy of automated prediction of clinical effect of copy number variations.

Clinical interpretation of copy number variants (CNVs) is a complex process that requires skilled clinical professionals. General recommendations have been recently released to guide the CNV interpret...

Eligibility for vericiguat in a real-world heart failure population according to trial, guideline and label criteria: Data from the Swedish Heart Failure Registry.

We investigated the eligibility for vericiguat in a real-world heart failure (HF) population based on trial, guideline and label criteria.... From the Swedish HF registry, 23 573 patients with HF with reduced ejection fraction (HFrEF) enrolled between 2000 and 2018, with a HF duration ≥6 months, were considered. Eligibility for vericiguat w... In a large and contemporary real-world HFrEF cohort, we estimated that 21.4% of patients would be eligible for vericiguat according to the VICTORIA trial selection criteria, 47.4% based on guidelines ...

Remote monitoring titration clinic to implement guideline-directed therapy for heart failure patients with reduced ejection fraction: a pilot quality-improvement intervention.

Guideline-directed medical therapy (GDMT) is the recommended treatment for heart failure with reduced ejection fraction (HFrEF). However, the implementation remains limited, with suboptimal use and do... HFrEF patients were randomly assigned to receive either usual care or a quality-improvement remote titration with remote monitoring intervention. The intervention group used wireless devices to transm... Baseline characteristics were similar (... The study suggests that a full-scale trial is feasible and that utilizing a remote titration clinic with remote monitoring has the potential to enhance the implementation of guideline-directed therapy...

Long-Term Impact of a Smartphone App on Prescriber Adherence to Antibiotic Guidelines for Adult Patients With Community-Acquired Pneumonia: Interrupted Time-Series Study.

Mobile health platforms like smartphone apps that provide clinical guidelines are ubiquitous, yet their long-term impact on guideline adherence remains unclear. In 2016, an antibiotic guidelines app, ... We aimed to assess whether the provision of antibiotic guidelines in a smartphone app resulted in sustained changes in antibiotic guideline adherence by prescribers.... We analyzed antibiotic guideline adherence rates during the first 24 hours of hospital admission in adults diagnosed with community-acquired pneumonia using an interrupted time-series study with 3 dis... Adherence increased from 23% (46/200) at baseline to 31% (73/237) at 3 months and 34% (69/200) at 12 months, reducing to 31% (62/200) at 24 months post app implementation (P=.07 vs baseline). However,... An antibiotic guidelines app increased overall adherence, but this was not sustained. In patients with pulmonary consolidation, the increased adherence was sustained....

Radiation therapy for vulvar cancer: consensus technical guidelines of the GINECOR working group of the Spanish Society of Radiation Oncology. Part 2: radiotherapy recommendations.

The present consensus statement was developed by the GINECOR working group on behalf of the Spanish Society of Radiation Oncology (SEOR). This document provides an up-to-date review of the technical a... A two-round modified Delphi study was conducted to reach consensus on the appropriateness of technical aspects of external beam radiotherapy and brachytherapy. Three clinical scenarios were proposed: ... The main recommendations on external beam radiotherapy and brachytherapy, both in adjuvant setting and local advanced disease are summarized. Recommendations include treatment technique, treatment vol... In the absence of robust clinical data, these recommendations may help to select the optimal radiotherapy approach for this relatively rare cancer....

Using tailored eHealth programmes to stimulate primary health care professionals' lifestyle counselling guideline adherence - Lessons learned from the STAR project.

Although individually tailored eHealth programmes have shown to be effective in changing patient and citizen health behaviours, they have so far not been applied to lifestyle counselling guideline adh... To identify lessons learned from our successful application of a tailored eHealth programme in primary health care.... Triangulation of information from different sources collected throughout the project run time (e.g., project meetings, discussions with experts in the fields of computer tailoring, smoking cessation a... We identify four lessons learned which developers and testers of tailored eHealth programmes in primary health care should consider, relating to 1) Choosing outcome measures, 2) Measuring outcomes, 3)... We share this information in the hope that we will see more applications of this promising intervention strategy - that can build on our work - in the future....